(0.49%) 5 042.96 points
(0.52%) 38 100 points
(0.91%) 15 748 points
(-0.59%) $78.53
(4.87%) $2.03
(0.07%) $2 312.70
(0.11%) $26.78
(0.78%) $962.35
(0.12%) $0.934
(0.01%) $11.03
(0.15%) $0.800
(-1.37%) $91.98
0.00% $ 36.01
Live Chart Being Loaded With Signals
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow...
Stats | |
---|---|
Dzisiejszy wolumen | 138 127 |
Średni wolumen | 762 778 |
Kapitalizacja rynkowa | 0.00 |
EPS | $-0.500 ( 2022-11-09 ) |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | 0 |
ATR14 | $0.674 (1.87%) |
Date | Person | Action | Amount | type |
---|---|---|---|---|
2023-01-11 | Keating Laurie | Sell | 11 904 | Stock Option (Right to Buy) |
2023-01-11 | Kariuki Enoch | Sell | 11 904 | Stock Option (Right to Buy) |
2023-01-11 | Tapper Amy E. | Sell | 141 094 | Common Stock |
2023-01-11 | Tapper Amy E. | Sell | 103 000 | Stock Option (Right to Buy) |
2023-01-11 | Rienhoff Hugh Jr | Sell | 501 702 | Common Stock |
INSIDER POWER |
---|
-50.69 |
Last 100 transactions |
Buy: 1 323 458 | Sell: 3 917 808 |
Wolumen Korelacja
Imago BioSciences, Inc. Korelacja
10 Najbardziej pozytywne korelacje |
---|
10 Najbardziej negatywne korelacje |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Imago BioSciences, Inc. Korelacja - Waluta/Towar
Imago BioSciences, Inc. Finanse
Annual | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.16 |
FY | 2021 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-3.16 |
FY | 2020 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-1.330 |
FY | 2019 |
Przychody: | $0.00 |
Zysk brutto: | $0.00 (0.00 %) |
EPS: | $-0.815 |
Financial Reports:
No articles found.
Imago BioSciences, Inc.
Imago BioSciences, Inc., a clinical stage biopharmaceutical company, discovers and develops small molecule product candidates that target lysine-specific demethylase 1(LSD1), an enzyme that used in the production of blood cells in the bone marrow. Its lead product candidate is bomedemstat, which is in Phase II clinical trials for the treatment of myeloproliferative neoplasms chronic cancers of the bone marrow, such as myelofibrosis, essential thrombocythemia, and polycythemia vera. The company was incorporated in 2012 and is headquartered in South San Francisco, California.
O Sygnały na żywo
Prezentowane na tej stronie sygnały na żywo pomagają określić, kiedy KUPIĆ lub SPRZEDAĆ BRAK DANYCH. Sygnały mogą mieć opóźnienie wynoszące nawet 1 minutę; jak wszystkie sygnały rynkowe, istnieje ryzyko błędu lub pomyłki.
Sygnały transakcyjne na żywo nie są ostateczne i getagraph.com nie ponosi odpowiedzialności za żadne działania podjęte na podstawie tych sygnałów, jak opisano w Warunkach Użytkowania. Sygnały opierają się na szerokim zakresie wskaźników analizy technicznej